| Dr Rainer Mederos, MD | |
|
3100 Sw 62nd Ave, Miami, FL 33155-3009 | |
| (305) 666-6511 | |
| Not Available |
| Full Name | Dr Rainer Mederos |
|---|---|
| Gender | Male |
| Speciality | Pediatrics |
| Location | 3100 Sw 62nd Ave, Miami, Florida |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1023268380 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208000000X | Pediatrics | ME102176 (Florida) | Primary |
| Entity Name | Bruce L Boros Md Pa |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1659443976 PECOS PAC ID: 1658359062 Enrollment ID: O20040712001204 |
News Archive
Insects may have tiny brains the size of a pinhead, but the latest research from the University of Adelaide shows just how clever they really are. For the first time, researchers from the University's Discipline of Physiology have worked out how insects judge the speed of moving objects.
New Phase II data, published today in the New England Journal of Medicine, showed that Eli Lilly and Company's ixekizumab, an anti-IL-17 monoclonal antibody, met its primary endpoint in patients with moderate-to-severe plaque psoriasis, with significantly more patients achieving at least a 75 percent improvement in Psoriasis Area and Severity Index (PASI) scores from baseline (PASI 75) compared with placebo at week 12.
By the time antibiotics made their clinical debut 70 years ago, bacteria had long evolved strategies to shield themselves. For billions of years, bacteria hurled toxic molecules at each other in the struggle to prosper, and those that withstood the chemical onslaught marched on.
Identifying the genetic malfunction that causes these disorders raises the hope that researchers may be able to devise a targeted therapy, just as they have done for chronic myelogenous leukemia (CML), which is presently treated with Gleevec. The three leukemias that share a common genetic cause are polycythemia vera (PV), essential thrombocythemia (ET) and myeloid metaplasia with myelofibrosis (MMM).
› Verified 3 days ago
| Entity Name | Md Now Medical Centers Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1033195474 PECOS PAC ID: 3971554825 Enrollment ID: O20050208000625 |
News Archive
Insects may have tiny brains the size of a pinhead, but the latest research from the University of Adelaide shows just how clever they really are. For the first time, researchers from the University's Discipline of Physiology have worked out how insects judge the speed of moving objects.
New Phase II data, published today in the New England Journal of Medicine, showed that Eli Lilly and Company's ixekizumab, an anti-IL-17 monoclonal antibody, met its primary endpoint in patients with moderate-to-severe plaque psoriasis, with significantly more patients achieving at least a 75 percent improvement in Psoriasis Area and Severity Index (PASI) scores from baseline (PASI 75) compared with placebo at week 12.
By the time antibiotics made their clinical debut 70 years ago, bacteria had long evolved strategies to shield themselves. For billions of years, bacteria hurled toxic molecules at each other in the struggle to prosper, and those that withstood the chemical onslaught marched on.
Identifying the genetic malfunction that causes these disorders raises the hope that researchers may be able to devise a targeted therapy, just as they have done for chronic myelogenous leukemia (CML), which is presently treated with Gleevec. The three leukemias that share a common genetic cause are polycythemia vera (PV), essential thrombocythemia (ET) and myeloid metaplasia with myelofibrosis (MMM).
› Verified 3 days ago
| Entity Name | Criticare Clinics Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1508871948 PECOS PAC ID: 7517966534 Enrollment ID: O20061220000143 |
News Archive
Insects may have tiny brains the size of a pinhead, but the latest research from the University of Adelaide shows just how clever they really are. For the first time, researchers from the University's Discipline of Physiology have worked out how insects judge the speed of moving objects.
New Phase II data, published today in the New England Journal of Medicine, showed that Eli Lilly and Company's ixekizumab, an anti-IL-17 monoclonal antibody, met its primary endpoint in patients with moderate-to-severe plaque psoriasis, with significantly more patients achieving at least a 75 percent improvement in Psoriasis Area and Severity Index (PASI) scores from baseline (PASI 75) compared with placebo at week 12.
By the time antibiotics made their clinical debut 70 years ago, bacteria had long evolved strategies to shield themselves. For billions of years, bacteria hurled toxic molecules at each other in the struggle to prosper, and those that withstood the chemical onslaught marched on.
Identifying the genetic malfunction that causes these disorders raises the hope that researchers may be able to devise a targeted therapy, just as they have done for chronic myelogenous leukemia (CML), which is presently treated with Gleevec. The three leukemias that share a common genetic cause are polycythemia vera (PV), essential thrombocythemia (ET) and myeloid metaplasia with myelofibrosis (MMM).
› Verified 3 days ago
| Entity Name | Urgent Care Physicians Of Palmetto Bay Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1740403914 PECOS PAC ID: 9032202049 Enrollment ID: O20070907000231 |
News Archive
Insects may have tiny brains the size of a pinhead, but the latest research from the University of Adelaide shows just how clever they really are. For the first time, researchers from the University's Discipline of Physiology have worked out how insects judge the speed of moving objects.
New Phase II data, published today in the New England Journal of Medicine, showed that Eli Lilly and Company's ixekizumab, an anti-IL-17 monoclonal antibody, met its primary endpoint in patients with moderate-to-severe plaque psoriasis, with significantly more patients achieving at least a 75 percent improvement in Psoriasis Area and Severity Index (PASI) scores from baseline (PASI 75) compared with placebo at week 12.
By the time antibiotics made their clinical debut 70 years ago, bacteria had long evolved strategies to shield themselves. For billions of years, bacteria hurled toxic molecules at each other in the struggle to prosper, and those that withstood the chemical onslaught marched on.
Identifying the genetic malfunction that causes these disorders raises the hope that researchers may be able to devise a targeted therapy, just as they have done for chronic myelogenous leukemia (CML), which is presently treated with Gleevec. The three leukemias that share a common genetic cause are polycythemia vera (PV), essential thrombocythemia (ET) and myeloid metaplasia with myelofibrosis (MMM).
› Verified 3 days ago
| Entity Name | Urgent Care Physicians Of West Kendall Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1508989757 PECOS PAC ID: 4789772591 Enrollment ID: O20071113000044 |
News Archive
Insects may have tiny brains the size of a pinhead, but the latest research from the University of Adelaide shows just how clever they really are. For the first time, researchers from the University's Discipline of Physiology have worked out how insects judge the speed of moving objects.
New Phase II data, published today in the New England Journal of Medicine, showed that Eli Lilly and Company's ixekizumab, an anti-IL-17 monoclonal antibody, met its primary endpoint in patients with moderate-to-severe plaque psoriasis, with significantly more patients achieving at least a 75 percent improvement in Psoriasis Area and Severity Index (PASI) scores from baseline (PASI 75) compared with placebo at week 12.
By the time antibiotics made their clinical debut 70 years ago, bacteria had long evolved strategies to shield themselves. For billions of years, bacteria hurled toxic molecules at each other in the struggle to prosper, and those that withstood the chemical onslaught marched on.
Identifying the genetic malfunction that causes these disorders raises the hope that researchers may be able to devise a targeted therapy, just as they have done for chronic myelogenous leukemia (CML), which is presently treated with Gleevec. The three leukemias that share a common genetic cause are polycythemia vera (PV), essential thrombocythemia (ET) and myeloid metaplasia with myelofibrosis (MMM).
› Verified 3 days ago
| Entity Name | Urgent Care Physicians Of Country Walk Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1689838849 PECOS PAC ID: 6204990385 Enrollment ID: O20090402000220 |
News Archive
Insects may have tiny brains the size of a pinhead, but the latest research from the University of Adelaide shows just how clever they really are. For the first time, researchers from the University's Discipline of Physiology have worked out how insects judge the speed of moving objects.
New Phase II data, published today in the New England Journal of Medicine, showed that Eli Lilly and Company's ixekizumab, an anti-IL-17 monoclonal antibody, met its primary endpoint in patients with moderate-to-severe plaque psoriasis, with significantly more patients achieving at least a 75 percent improvement in Psoriasis Area and Severity Index (PASI) scores from baseline (PASI 75) compared with placebo at week 12.
By the time antibiotics made their clinical debut 70 years ago, bacteria had long evolved strategies to shield themselves. For billions of years, bacteria hurled toxic molecules at each other in the struggle to prosper, and those that withstood the chemical onslaught marched on.
Identifying the genetic malfunction that causes these disorders raises the hope that researchers may be able to devise a targeted therapy, just as they have done for chronic myelogenous leukemia (CML), which is presently treated with Gleevec. The three leukemias that share a common genetic cause are polycythemia vera (PV), essential thrombocythemia (ET) and myeloid metaplasia with myelofibrosis (MMM).
› Verified 3 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Rainer Mederos, MD 3100 Sw 62nd Ave, Miami, FL 33155-3009 Ph: (305) 666-6511 | Dr Rainer Mederos, MD 3100 Sw 62nd Ave, Miami, FL 33155-3009 Ph: (305) 666-6511 |
News Archive
Insects may have tiny brains the size of a pinhead, but the latest research from the University of Adelaide shows just how clever they really are. For the first time, researchers from the University's Discipline of Physiology have worked out how insects judge the speed of moving objects.
New Phase II data, published today in the New England Journal of Medicine, showed that Eli Lilly and Company's ixekizumab, an anti-IL-17 monoclonal antibody, met its primary endpoint in patients with moderate-to-severe plaque psoriasis, with significantly more patients achieving at least a 75 percent improvement in Psoriasis Area and Severity Index (PASI) scores from baseline (PASI 75) compared with placebo at week 12.
By the time antibiotics made their clinical debut 70 years ago, bacteria had long evolved strategies to shield themselves. For billions of years, bacteria hurled toxic molecules at each other in the struggle to prosper, and those that withstood the chemical onslaught marched on.
Identifying the genetic malfunction that causes these disorders raises the hope that researchers may be able to devise a targeted therapy, just as they have done for chronic myelogenous leukemia (CML), which is presently treated with Gleevec. The three leukemias that share a common genetic cause are polycythemia vera (PV), essential thrombocythemia (ET) and myeloid metaplasia with myelofibrosis (MMM).
› Verified 3 days ago
Dr. Juanita Ann Marie Hunter, M.D. Pediatrics Medicare: Accepting Medicare Assignments Practice Location: 1611 Nw 12th Ave, Miami, FL 33136 Phone: 305-585-6042 | |
Keerthana Reddy Banala, Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 1611 Nw 12th Ave # 6006, Miami, FL 33136 Phone: 305-585-6017 Fax: 305-325-0293 | |
Dr. Maria Del Pilar Rivero, MD Pediatrics Medicare: Medicare Enrolled Practice Location: 1611 Nw 12th Ave, Miami, FL 33136 Phone: 786-466-6908 Fax: 786-466-6920 | |
Stephanie Dechurch, MD Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 7800 Sw 87th Ave, C-350, Miami, FL 33173 Phone: 305-271-4711 Fax: 305-271-8732 | |
Gloria E Burgos, MD Pediatrics Medicare: Medicare Enrolled Practice Location: 3601 Federal Hwy, Miami, FL 33137 Phone: 305-576-6611 Fax: 305-576-0008 | |
Dr. Teresita Fox, M.D. Pediatrics Medicare: Medicare Enrolled Practice Location: 3100 Sw 62nd Ave, Miami, FL 33155 Phone: 561-624-9188 Fax: 561-514-7217 | |
Bridget Buzzella, MD Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 3100 Sw 62nd Ave, Miami, FL 33155 Phone: 305-662-8357 |